We are live on ! Find out more
Macquarie Group

Macquarie Group Portfolio holdings

AUM $16.8B
1-Year Est. Return 27.39%
This Fund
S&P 500
This Quarter Est. Return
+10.75%
1 Year Est. Return
+27.39%
3 Year Est. Return
+81.07%
5 Year Est. Return
+109.03%
10 Year Est. Return
+396.55%
AUM
$84.7B
AUM Growth
+$3.15B
Cap. Flow
-$3.2B
Cap. Flow %
-3.77%
Top 10 Hldgs %
10.93%
Holding
2,264
New
35
Increased
617
Reduced
853
Closed
525

Top Buys

Rank Stock Value
1
LHX icon
L3Harris
LHX
+$128M
2
DHR icon
Danaher
DHR
+$114M
3
ZBRA icon
Zebra Technologies
ZBRA
+$112M
4
AIZ icon
Assurant
AIZ
+$92.7M
5
EXC icon
Exelon
EXC
+$92.2M

Sector Composition

Rank Sector Weight
1 Technology 21.36%
2 Healthcare 15.17%
3 Financials 13.51%
4 Industrials 10.72%
5 Consumer Discretionary 9.33%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AKR icon
1526
Acadia Realty Trust
AKR
$2.99B
$245K ﹤0.01%
17,052
-3,647
-18% -$51.5K
DAVA icon
1527
Endava
DAVA
$141M
$239K ﹤0.01%
+3,127
New +$233K
CACC icon
1528
Credit Acceptance
CACC
$6B
$237K ﹤0.01%
499
-117
-19% -$53.7K
CABO icon
1529
Cable One
CABO
$213M
$231K ﹤0.01%
325
-28,128
-99% -$21M
BDN
1530
Brandywine Realty Trust
BDN
$551M
$231K ﹤0.01%
37,495
-4,074,464
-99% -$26.2M
AMRN
1531
Amarin Corp
AMRN
$284M
$230K ﹤0.01%
9,500
MIDD icon
1532
Middleby
MIDD
$6.05B
$230K ﹤0.01%
1,720
-474
-22% -$64.5K
PGRE
1533
DELISTED
Paramount Group
PGRE
$227K ﹤0.01%
38,273
+578
+2% +$3.61K
TWST icon
1534
Twist Bioscience
TWST
$5.62B
$220K ﹤0.01%
9,252
-7,127
-44% -$207K
PAAS icon
1535
Pan American Silver
PAAS
$18.6B
$219K ﹤0.01%
13,438
-923
-6% -$14.8K
AIV
1536
Aimco
AIV
$380M
$219K ﹤0.01%
36,157
+3,415
+10% +$26K
VMEO
1537
DELISTED
Vimeo
VMEO
$218K ﹤0.01%
63,493
-47,555
-43% -$184K
NWL icon
1538
Newell Brands
NWL
$2.16B
$217K ﹤0.01%
16,574
+5,646
+52% +$77.1K
GFS icon
1539
GlobalFoundries
GFS
$29.4B
$213K ﹤0.01%
3,950
+1,830
+86% +$107K
NXTC icon
1540
NextCure
NXTC
$17.3M
$212K ﹤0.01%
12,500
ZIM icon
1541
ZIM Integrated Shipping Services
ZIM
$3B
$210K ﹤0.01%
12,208
+4,179
+52% +$93K
AEG icon
1542
Aegon
AEG
$13.5B
$209K ﹤0.01%
41,400
+6,885
+20% +$31.9K
AGM icon
1543
Federal Agricultural Mortgage
AGM
$2.27B
$209K ﹤0.01%
1,852
-8,198
-82% -$943K
ILPT
1544
Industrial Logistics Properties Trust
ILPT
$613M
$209K ﹤0.01%
63,789
UHT
1545
Universal Health Realty Income Trust
UHT
$608M
$206K ﹤0.01%
4,310
-9,216
-68% -$444K
FHN icon
1546
First Horizon
FHN
$12.1B
$202K ﹤0.01%
8,236
-80,820
-91% -$1.96M
DAL icon
1547
Delta Air Lines
DAL
$55.9B
$199K ﹤0.01%
6,047
+3,830
+173% +$127K
Z icon
1548
Zillow
Z
$7.04B
$196K ﹤0.01%
6,090
+734
+14% +$24.3K
IXC icon
1549
iShares Global Energy ETF
IXC
$2.71B
$195K ﹤0.01%
5,000
NTES icon
1550
NetEase
NTES
$76.5B
$193K ﹤0.01%
2,662

Similar funds

Macquarie Group's Q4 2022 Portfolio in Review

As of Q4 2022, Macquarie Group held 2,264 positions worth $84.7B, up 3.9% from $81.5B the previous quarter. Its ten largest holdings account for 11% of the portfolio.

Macquarie Group withdrew a net $3.2B in Q4 2022, closing 525 positions and reducing 853 holdings. Its most notable exit was Abiomed Inc, an estimated $124M position sold in full.

By sector, the portfolio is most concentrated in Technology at 21% of assets, down from 22% a quarter earlier, followed by Healthcare and Financials.

Against the trend, Macquarie Group opened a new position in iShares 0-5 Year Investment Grade Corporate Bond ETF worth $58.3M.

  • Macquarie Group's largest Q4 2022 buy was iShares 0-5 Year Investment Grade Corporate Bond ETF: 1,218,670 shares worth $58.3M.
  • Macquarie Group added most to L3Harris in Q4 2022, an estimated $128M increase.
  • Macquarie Group's biggest Q4 2022 reduction was Microsoft, cutting an estimated $189M.
  • Macquarie Group fully exited Abiomed Inc in Q4 2022, selling an estimated $124M.
  • Macquarie Group's ten largest holdings make up 11% of its $84.7B portfolio in Q4 2022.
  • Macquarie Group opened 35 new positions and closed 525 in Q4 2022.
  • Macquarie Group's portfolio value rose 3.9% quarter-over-quarter to $84.7B.

Based on Macquarie Group's 13F filing for Q4 2022, filed 21 Feb 2023.